Novocure (NASDAQ: NVCR) is an oncology company pioneering a novel therapy for solid tumors called Tumor Treating Fields, or TTFields.
Location: United States, New Hampshire, Portsmouth
Employees: 1001-5000
Founded date: 2000
Investors 3
Date | Name | Website |
15.04.2021 | Viceroy Ve... | viceven.co... |
- | Autonomy V... | autonomyve... |
- | Annox Capi... | annoxcapit... |
Mentions in press and media 9
Date | Title | Description | Source |
28.11.2023 | Today’s biotech news roundup, in under 800 words | Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne... | statnews.c... |
21.06.2022 | xCures and Novocure® partner to better understand quality of... | Innovative collaboration focused on developing the first comprehensive Quality of Life dataset for g... | einpresswi... |
10.05.2022 | Life-Sciences Company, Detact Diagnostics, Selects New Hamps... | New Hampshire's life science/medical device sector includes over 600 companies and employs over 7,00... | prweb.com/... |
25.02.2021 | Novocure Reports Fourth Quarter and Full Year 2020 Financial... | ST. HELIER, Jersey--(BUSINESS WIRE)--Feb 25, 2021-- Novocure (NASDAQ: NVCR) today reported financial... | oaoa.com/n... |
24.12.2019 | Why is glioblastoma such a tough nut to crack? | The latest letdowns came in just the last few months. In September, San Diego-based Tocagen announce... | medcitynew... |
24.05.2019 | Novocure bags mesothelioma nod for electric fields cance... | Mary Hesdorffer Mesothelioma Applied Research Foundation Novocure has secured the FDA’s ble... | endpts.com... |
08.02.2018 | Sage seeks $575M in public offering; Pfizer inks discov... | → Sage Therapeutics is hoping to raise a whopping $575 million through its latest public of... | endpts.com... |
08.01.2015 | Novocure Enteres into $100M Term Loan Agreement with Pharmak... | Novocure, a commercial stage oncology company, entered into a term loan agreement with an investment... | finsmes.co... |
- | Why is glioblastoma such a tough nut to crack? | However often people refer to “cancer” in the singular, it’s more accurate to see it as a spectrum o... | medcitynew... |